Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome
about
Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation.Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical managementThe presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy
P2860
Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Minimum Residual Disease in Pa ...... ications and Treatment Outcome
@en
Minimum Residual Disease in Pa ...... ications and Treatment Outcome
@nl
type
label
Minimum Residual Disease in Pa ...... ications and Treatment Outcome
@en
Minimum Residual Disease in Pa ...... ications and Treatment Outcome
@nl
prefLabel
Minimum Residual Disease in Pa ...... ications and Treatment Outcome
@en
Minimum Residual Disease in Pa ...... ications and Treatment Outcome
@nl
P2093
P2860
P1476
Minimum Residual Disease in Pa ...... ications and Treatment Outcome
@en
P2093
Anibal Salazar
Cynthia Fuentealba
Eduardo Reyes
Nigel P Murray
Socrates Aedo
P2860
P304
P356
10.22034/APJCP.2018.19.1.229
P577
2018-01-27T00:00:00Z